CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment. The company utilizes conditional activation platform technology for on...
Leadership
Sean A. McCarthy DPHIL
Chairman & CEO
Christopher W. Ogden
SVP, CFO & Secretary
Rachael Lester
Chief Business Officer & Senior VP
Marcia P. Belvin Ph.D.
Senior VP & Chief Scientific Officer
Lloyd A. Rowland Jr., J.D.
Senior VP, General Counsel, Chief Compliance Officer & Secretary
Danielle Olander-Moghadassian
Senior VP & Chief Human Resources Officer
Leslie Robbins J.D.
Senior Vice President of Intellectual Property
Yu-Waye Chu M.D.
Senior VP & Chief Medical Officer
Dawn Benson
Senior Vice President of Quality & Product Manufacturing
Stephanie Robertson Ph.D.
Senior Vice President of Alliances & Program Leadership
